Stockreport

Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results [Yahoo! Finance]

Traws Pharma, Inc.  (TRAW) 
PDF ritonavir, and with a lower likelihood of clinical rebound and good overall tolerability Flu : Phase 1 pharmacokinetic profile supports the potential for tivoxavir mar [Read more]